Impaired long-term depression in schizophrenia: A cathodal tDCS pilot study

by Alkomiet Hasan, Michael A. Nitsche, Maximiliane Herrmann, Thomas Schneider-Axmann, Louise Marshall, Oliver Gruber, Peter Falkai, Thomas Wobrock
Published 2012-10-01

Effect of aerobic exercise on cortical thickness in patients with schizophrenia—A dataset

by Shun Takahashi, Daniel Keeser, Boris-Stephan Rauchmann, Thomas Schneider-Axmann, Katriona Keller-Varady, Isabel Maurus, Peter Dechent, Thomas Wobrock, Alkomiet Hasan, Andrea Schmitt, Birgit Ertl-Wagner, Berend Malchow, Peter Falkai
Published 2020-06-01

Add-on spironolactone as antagonist of the NRG1-ERBB4 signaling pathway for the treatment of schizophrenia: Study design and methodology of a multicenter randomized, placebo-contro...

by Alkomiet Hasan, Astrid Roeh, Stefan Leucht, Berthold Langguth, Maximilian Hansbauer, Tatiana Oviedo-Salcedo, Sophie K. Kirchner, Irina Papazova, Lisa Löhrs, Elias Wagner, Isabel Maurus, Wolfgang Strube, Moritz J. Rossner, Michael C. Wehr, Ingrid Bauer, Stephan Heres, Claudia Leucht, Peter M. Kreuzer, Stephanie Zimmermann, Thomas Schneider-Axmann, Thomas Görlitz, Susanne Karch, Silvia Egert-Schwender, Beate Schossow, Philipp Rothe, Peter Falkai
Published 2020-03-01